Skip to main content

Bruce Jackson

Analyst

Benchmark

Equibles does not estimate personal net worth.

About Bruce Jackson

Bruce Jackson is recorded as Analyst at Benchmark. Bruce Jackson has spoken on 3 earnings calls across 2 companies, most recently for BioStem Technologies, Inc. on August 12, 2026. Those appearances were for BioStem Technologies, Inc. (BSEM) and Belite Bio, Inc (BLTE). The companies whose calls Bruce Jackson spoke on are classified in the Healthcare sector.

Bruce Jackson on recent calls

“Last quarter, you discussed making some hires in the sales reps, targeting around 40 by year-end. Is that still the case? And where are you in terms of reaching that target?”
Analyst — Benchmark, August 12, 2026 4:30 PM ET BioStem Technologies Second Quarter 2026 Earnings Call ·
“I wanted to go back to the gross margins with bringing the biotissue products in-house. When do you think you're going to have those products in-house, and then how do the gross margins expand from there?”
Analyst — Benchmark, March 24, 2026 4:30 PM ET BioStem Technologies Fourth Quarter and Full Year 2025 Earnings Call ·
“And then if I could just get a follow-up on the ex-U.S. regulatory strategy. You've got quite a bit going on this year. Do you intend to seek further approvals in Europe, and when might those get submitted?”
Analyst — Benchmark, Belite Bio, Inc Q4 FY2025 Earnings Call ·

Affiliation history

  • Benchmark

    Analyst

    Transcript header (unverified)

    Current

Company network

Recent activity